The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The applications of Vitamin E TPGS in drug delivery
Abstract
D-α-Tocopheryl polyethylene glycol 1000 succinate (simply TPGS or Vitamin E TPGS) is formed by the esterification of Vitamin E succinate with polyethylene glycol 1000. As novel nonionic surfactant, it exhibits amphipathic properties and can form stable micelles in aqueous vehicles at concentration as low as 0.02 wt%. It has been widely investigated for its emulsifying, dispersing, gelling, and solubilizing effects on poorly water-soluble drugs. It can also act as a P-glycoprotein (P-gp) inhibitor and has been served as an excipient for overcoming multidrug resistance (MDR) and for increasing the oral bioavailability of many anticancer drugs. Since TPGS has been approved by FDA as a safe pharmaceutic adjuvant, many TPGS-based drug delivery systems (DDS) have been developed. In this review, we discuss TPGS properties as a P-gp inhibitor, solubilizer/absorption and permeation enhancer in drug delivery and TPGS-related formulations such as nanocrystals, nanosuspensions, tablets/solid dispersions, adjuvant in vaccine systems, nutrition supplement, plasticizer of film, anticancer reagent and so on. This review will greatly impact and bring out new insights in the use of TPGS in DDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586
Self-citationEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
Sethia, S., & Squillante, E. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.025 · Cited by 442
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426
ESPEN guidelines for nutrition in liver disease and transplantation
Plauth, M., Merli, M., Kondrup, J., Weimann, A., Ferenci, P., & Müller, M. J. (1997) · Clinical Nutrition · doi:10.1016/s0261-5614(97)80022-2 · Cited by 421
Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Collnot, E.-M., Baldes, C., Wempe, M. F., Kappl, R., Hüttermann, J., Hyatt, J. A., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060121r · Cited by 280
Ghosh, I., Bose, S., Vippagunta, R., & Harmon, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.051 · Cited by 265
Mi, Y., Liu, Y., & Feng, S.-S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.022 · Cited by 261
A screening study of surface stabilization during the production of drug nanocrystals
Van Eerdenbrugh, B., Vermant, J., Martens, J. A., Froyen, L., Van Humbeeck, J., Augustijns, P., & Van den Mooter, G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21563 · Cited by 242
Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., & Borchardt, R. T. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10176 · Cited by 237
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Yu, L., Bridgers, A., Polli, J., Vickers, A., Long, S., Roy, A., Winnike, R., & Coffin, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018939006780 · Cited by 225
Baert, L., van ‘t Klooster, G., Dries, W., François, M., Wouters, A., Basstanie, E., Iterbeke, K., Stappers, F., Stevens, P., Schueller, L., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.006 · Cited by 224
Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion
Crowley, M. M., Zhang, F., Koleng, J. J., & McGinity, J. W. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00187-4 · Cited by 222
Collnot, E.-M., Baldes, C., Schaefer, U. F., Edgar, K. J., Wempe, M. F., & Lehr, C.-M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900191s · Cited by 219
ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
Kerb, R., Hoffmeyer, S., & Brinkmann, U. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.1.51 · Cited by 202
Johnson, B. M., Charman, W. N., & Porter, C. J. H. (2002) · AAPS PharmSci · doi:10.1208/ps040440 · Cited by 193
Bogman, K., Erne-Brand, F., Alsenz, J., & Drewe, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10395 · Cited by 184
Collnot, E.-M., Baldes, C., Wempe, M. F., Hyatt, J., Navarro, L., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.005 · Cited by 184
Buckley, S. T., Fischer, S. M., Fricker, G., & Brandl, M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.12.007 · Cited by 179
Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
Liu, Y., Huang, L., & Liu, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100012s · Cited by 168
Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol
YOUK, H., LEE, E., CHOI, M., LEE, Y., CHUNG, J., KIM, S., LEE, C., & LIM, S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.014 · Cited by 165
Vandecruys, R., Peeters, J., Verreck, G., & Brewster, M. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.006 · Cited by 163
Cyclosporine A-Induced Oxidative Stress in Rat Hepatocytes
Wolf, A., Trendelenburg, C.-F., Diez-Fernandez, C., Prieto, P., Houy, S., Trommer, W. E., & Cordier, A. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36544-9 · Cited by 162
Anstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
Khandavilli, S., & Panchagnula, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700485 · Cited by 158
Advances in the Use of Tocols as Drug Delivery Vehicles
Constantinides, P. P., Han, J., & Davis, S. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9262-9 · Cited by 138
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
Akhtar, N., Ahad, A., Khar, R. K., Jaggi, M., Aqil, M., Iqbal, Z., Ahmad, F. J., & Talegaonkar, S. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.561784 · Cited by 133
Sokol, R. J., Butler–Simon, N., Conner, C. L., Heubi, J. E., SINATRA, F. R., Suchy, F. J., Heyman, M. B., Perrault, J. F., Rothbaum, R., Levy, J. F., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90652-s · Cited by 130
Traber, M. G., Kayden, H., Green, J., & Green, M. H. (1986) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/44.6.914 · Cited by 126
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
Bogman, K., Aschmann, Y. Z., DEGEN, L., Gérard Hopfgartner, D., Gutmann, H., Alsenz, J., & Drewe, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.001 · Cited by 126
Gao, Y., Li, Z., Sun, M. H., Li, H., Guo, C., Cui, J., Li, A., Cao, F., Xi, Y., Lou, H., et al. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003695139 · Cited by 124
The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers*
Chang, T. T., Benet, L. Z., & Hébert, M. F. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80007-5 · Cited by 122
Water-Insoluble Drug Formulation
Ron, L. (2000) · CRC Press eBooks · doi:10.1201/9781420026054 · Cited by 119
Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion
Repka, M. A., & McGinity, J. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00365-5 · Cited by 118
Prasad, Y. V. R., Puthli, S. P., Eaimtrakarn, S., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00544-6 · Cited by 118
Dahe, G. J., Teotia, R. S., Kadam, S. S., & Bellare, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.005 · Cited by 110
Effect of excipients on breast cancer resistance protein substrate uptake activity
Yamagata, T., Kusuhara, H., Morishita, M., Takayama, K., Benameur, H., & Sugiyama, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.021 · Cited by 108
Janssens, S., Nagels, S., de Armas, H. N., D’Autry, W., Schepdael, A. V., & den Mooter, G. V. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.11.004 · Cited by 104
Fischer, S. M., Brandl, M., & Fricker, G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.010 · Cited by 102
Brouwers, J., Tack, J. F., Lammert, F., & Augustijns, P. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20553 · Cited by 99
Christiansen, A., Backensfeld, T., & Weitschies, W. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.07.005 · Cited by 98
Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro
Christiansen, A., Backensfeld, T., Denner, K., & Weitschies, W. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.033 · Cited by 97
Yan, A., Von Dem Bussche, A., Kane, A. B., & Hurt, R. H. (2007) · Carbon · doi:10.1016/j.carbon.2007.08.035 · Cited by 95
Hanke, U., May, K. E., Rozehnal, V., Nagel, S., Siegmund, W., & Weitschies, W. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.008 · Cited by 94
Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects
Mi, Y., Zhao, J., & Feng, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.038 · Cited by 91
Eerdenbrugh, B. V., Vercruysse, S., Martens, J. A., Vermant, J., Froyen, L., Jan, V. H., Guy, V. D. M., & Augustijns, P. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.007 · Cited by 88
Argào, E. A., Heubi, J. E., Hollis, B. W., & Tsang, R. C. (1992) · Pediatric Research · doi:10.1203/00006450-199202000-00011 · Cited by 84
NMR Study of the Association of Propofol with Nonionic Surfactants
Momot, K. I., Kuchel, P. W., Chapman, B. E., Deo, P., & Whittaker, D. V. (2003) · Langmuir · doi:10.1021/la026722g · Cited by 83
SOKOL, R., Johnson, K. E., Karrer, F. M., Narkewicz, M. R., Smith, D. J., & Kam, I. (1991) · The Lancet · doi:10.1016/0140-6736(91)90349-t · Cited by 82
de Smidt, P. C., Campanero, M. Á., & Trocóniz, I. F. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.036 · Cited by 82
Sadoqi, M., Lau‐Cam, C. A., & Wu, S. H. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.01.048 · Cited by 80
The effect of α-tocopherol on the in vitro solubilisation of lipophilic drugs
Nielsen, P. B., Müllertz, A., Norling, T., & Kristensen, H. G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00701-3 · Cited by 72
Sheu, M., Chen, S., Chen, L.-C., & Ho, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00492-3 · Cited by 67
Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS
Wempe, M. F., Wright, C., Little, J. L., Lightner, J., Large, S. E., Caflisch, G. B., Buchanan, C. M., Rice, P. J., Wacher, V. J., & Ruble, K. M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.021 · Cited by 65
Katneni, K., Charman, S. A., & Porter, C. J. H. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20687 · Cited by 64
Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis
Nikonenko, B. V., Reddy, V. M., Protopopova, M. N., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-09 · Cited by 63
Fischer, S. M., Flaten, G. E., Hagesæther, E., Fricker, G., & Brandl, M. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01301.x · Cited by 62
Fulzele, S. V., Chatterjee, A., Shaik, M. S., Jackson, T., & Singh, M. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9074-6 · Cited by 60
Krasavage, W. J., & Terhaar, C. J. (1977) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60210a002 · Cited by 57
Mudra, D. R., & Borchardt, R. T. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21836 · Cited by 55
Bioavailability of a Novel, Water-Soluble Vitamin E Formulation in Malabsorbing Patients
Papas, K. A., Kalbfleisch, J. H., & MOHON, R. T. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9489-2 · Cited by 52
Excipient effects on gastrointestinal transit and drug absorption in beagle dogs
Schulze, J. D. R., Peters, E. E., Vickers, A. W., Staton, J. S., Coffin, M. D., Parsons, G. E., & Basit, A. W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.004 · Cited by 48
Wu, S., & Hopkins, W. (1999) · Pharmaceutical technology · Cited by 47
Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects
Kuentz, M. (2011) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(11)50002-4 · Cited by 46
Bittner, B., Guenzi, A., Fullhardt, P., Zürcher, G., González, R., & Mountfield, R. J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1299951 · Cited by 43
Xu, H., Abe, H., Naito, M., Fukumori, Y., Ichikawa, H., Endoh, S., & Hata, K. (2010) · Advanced Powder Technology · doi:10.1016/j.apt.2010.02.011 · Cited by 37
Boudreaux, J. P., Hayes, D. H., Mizrahi, S. S., Maggiore, P., Blazek, J., & Dick, D. (1993) · PubMed · Cited by 36
Schamp, K., Schreder, S., & Dressman, J. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.08.009 · Cited by 35
Sethia, S., & Squillante, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20199 · Cited by 34
Fischer, J. R., Harkin, K. R., & Lc, F. (2002) · PubMed · Cited by 34
Dong, Y., Zhang, Z., & Feng, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.043 · Cited by 33
Self-citationDahe, G. J., Kadam, S. S., Sabale, S. S., Kadam, D. P., Sarkate, L. B., & Bellare, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025236 · Cited by 28
Can changes in hydrophobicity increase the bioavailability of α–tocopherol?
Back, E. I., Frindt, C., Ocenaskova, E., et al. (2005) · European Journal of Nutrition · doi:10.1007/s00394-005-0556-9 · Cited by 23
Jin, F., & Tatavarti, A. S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.017 · Cited by 20
Feasibility of Interstitial CT Lymphography Using Optimized Iodized Oil Emulsion in Rats
Chung, Y. E., Hyung, W. J., Kweon, S., Lim, S.-J., Choi, J., Lee, M. H., Kim, H., Myoung, S., & Lim, J. S. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181c8cf19 · Cited by 18
Katneni, K., Charman, S. A., & Porter, C. J. H. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20877 · Cited by 18
Impact of formulation excipients on human intestinal transit
Schulze, J. D. R., Ashiru-Oredope, D. A. I., Khela, M. K., Evans, D. F., Patel, R., Parsons, G. E., Coffin, M. D., & Basit, A. W. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0012 · Cited by 17
Beneficial Effect of α-Tocopheryl Succinate in Rat Cardiac Transplants
Nguyen, T. K., Nilakantan, V., Felix, C. C., Khanna, A. K., & Pieper, G. M. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.02.007 · Cited by 16
Pharmacokinetic Profiles of Coenzyme Q10: Absorption of Three Different Oral Formulations in Rats
Nishimura, A., Yanagawa, H., Fujikawa, N., Kiriyama, A., & Shibata, N. (2009) · Eisei kagaku · doi:10.1248/jhs.55.540 · Cited by 15
Barakat, N. S., Elanazi, F. K., & Almurshedi, A. S. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802305113 · Cited by 8
Cited by
Xu, W., Ling, P., & Zhang, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/340315 · Cited by 595
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Development of High‐Drug‐Loading Nanoparticles
Liu, Y., Yang, G., Jin, S., Xu, L., & Zhao, C. (2020) · ChemPlusChem · doi:10.1002/cplu.202000496 · Cited by 410
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Yang, C., Wu, T., Qi, Y., & Zhang, Z. (2018) · Theranostics · doi:10.7150/thno.22711 · Cited by 402
Self-citationSurface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
Metadata
- Authors
- Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 49
- Issue
- 2
- Pages
- 175-186
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2061215349
- Cited by
- 523
- References
- 87
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.